• 1
    Adams SA, Hebert JR, Bolick-Aldrich S, et al. Breast cancer disparities in South Carolina: early detection, special programs, and descriptive epidemiology. J S C Med Assoc. 2006; 102: 231-239.
  • 2
    Li CI. Racial and ethnic disparities in breast cancer stage, treatment, and survival in the United States. Ethn Dis. 2005; 15: S5-S9.
  • 3
    Eley JW, Hill HA, Chen VW, et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA. 1994; 272: 947-954.
  • 4
    Freeman HP. The meaning of race in cancer of the breast. Cancer J Sci Am. 1997; 3: 76-77.
  • 5
    Krieger N, Van Den Eden SK, Zava D, Okamoto A. Race/ethnicity, social class, and prevalence of breast cancer prognostic biomarkers: a study of white, black, and Asian women in the San Francisco Bay Area. Ethn Dis. 1997; 7: 137-149.
  • 6
    Moorman PG, Jones BA, Millikan RC, Hall IJ, Newman B. Race, anthropometric factors, and stage at diagnosis of breast cancer. Am J Epidemiol. 2001; 153: 284-291.
  • 7
    Rose DP, Royak-Schaler R. Tumor biology and prognosis in black breast cancer patients. Cancer Detect Prev. 2001; 25: 16-31.
  • 8
    El-Tamer MB, Homel P, Wait R. Is race a poor prognostic factor in breast cancer? J Am Coll Surg. 1999; 189: 41-45.
  • 9
    Marbella AM, Layde PM. Racial trends in age-specific breast cancer mortality rates in US women. Am J Public Health. 2001; 91: 118-121.
  • 10
    Aldridge ML, Daniels JL, Jukic AM. Mammograms and healthcare access among US Hispanic and non-Hispanic women 40 years and older. Fam Commun Health. 2006; 29: 80-88.
  • 11
    Qureshi M, Thacker HL, Litaker DG, Kippes C. Differences in breast cancer screening rates: an issue of ethnicity or socioeconomics? J Womens Health Gend Based Med. 2000; 9: 1025-1031.
  • 12
    Wojcik B, Spinks M. Can racial differences in breast carcinoma survival be explained by access to medical care? Cancer. 2000; 88( suppl): 1268-1269.
  • 13
    Sanders LC, Hardy WR, Ashford-Carroll TS, Bolick-Aldrich SW. South Carolina Cancer Facts and Figures 2001-2002. Charleston, SC: South Carolina Central Cancer Registry, Office of Public Health Statistics and Information Services, South Carolina Department of Health and Environmental Control; American Cancer Society, Southeast Division; 2001.
  • 14
    Cunningham JE, Butler WM. Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis. Breast Cancer Res Treat. 2004; 88: 161-176.
  • 15
    Wojcik BE, Spinks MK, Optenberg SA. Breast carcinoma survival analysis for African American and white women in an equal-access health care system. Cancer. 1998; 82: 1310-1318.
  • 16
    Chen V, Correa P, Kurman R, et al. Histological characteristics of breast carcinoma in blacks and whites. Cancer Epidemiol Biomarkers Prev. 1994; 3: 127-135.
  • 17
    McCarthy EP, Burns RB, Coughlin SS, et al. Mammography use helps to explain differences in breast cancer stage at diagnosis between older black and white women. Ann Intern Med. 1998; 128: 729-736.
  • 18
    Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A. Screening for breast cancer in women aged under 50: mode of detection, incidence, fatality, and histology. J Med Screen. 1995; 2: 94-98.
  • 19
    Kerlikowske K, Barclay J. Outcomes of modern screening mammography. J Natl Cancer Inst Monogr. 1997; 22: 105-111.
  • 20
    Jones BA, Patterson EA, Calvocoressi L. Mammography screening in African-American women: evaluating the research. Cancer. 2003; 97: 258-272.
  • 21
    Caplan LS, Helzlsouer KJ, Shapiro S, Wesley MN, Edwards BK. Reasons for delay in breast cancer diagnosis. Prev Med. 1996; 25: 218-224.
  • 22
    McCarthy BD, Yood MU, Boohaker EA, Ward RE, Rebner M, Johnson CC. Inadequate follow-up of abnormal mammograms. Am J Prev Med. 1996; 12: 282-288.
  • 23
    McCarthy BD, Yood MU, Janz NK, Boohaker EA, Ward RE, Johnson CC. Evaluation of factors potentially associated with inadequate follow-up of mammographic abnormalities. Cancer. 1996; 77: 2070-2076.
  • 24
    Weinmann S, Taplin SH, Gilbert J, et al. Characteristics of women refusing follow-up for tests or symptoms suggestive of breast cancer. J Natl Cancer Inst Monogr. 2005; 35: 33-38.
  • 25
    Kerlikowske K. Timeliness of follow-up after abnormal screening mammography. Breast Cancer Res Treat. 1996; 40: 53-64.
  • 26
    Caplan LS, Schoenfeld ER, O'Leary ES, Leske MC. Breast cancer and electromagnetic fields. Ann Epidemiol. 2000; 10: 31-44.
  • 27
    Elmore JG, Wells CK, Howard DH, Feinstein AR. The impact of clinical history on mammographic interpretations. JAMA. 1997; 277: 49-52.
  • 28
    Chang S, Hulka BS, Baird DD, et al. Breast cancer survival and the timing of tumor removal during the menstrual cycle. Cancer Epidemiol Biomarkers Prev. 1997; 6: 881-886.
  • 29
    Kerner JF, Guirguis-Blake J, Hennessy KD, et al. Translating research into improved outcomes in comprehensive cancer control. Cancer Causes Control. 2005; 16: 27-40.
  • 30
    American College of Radiology. Breast Imaging Reporting and Data System (BI-RADS) Atlas. Reston, Va: American College of Radiology; 2003.
  • 31
    Fleming ID, Cooper Js, Hensen DE, et al, eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, Pa: Lippincott-Raven; 1998.
  • 32
    Williams R. A note on robust variance estimation for cluster-correlated data. Biometrics. 2000; 56: 645-646.
  • 33
    Lin DY, Wei LJ. The robust inference for the Cox proportional hazards model. J Am Stat Assoc. 1989; 84: 1074-1078.
  • 34
    Caplan LS, Helzlsouer KJ, Shapiro S, Freedman LS, Coates RJ, Edwards BK. System delay in breast cancer in whites and blacks. Am J Epidemiol. 1995; 142: 804-812.
  • 35
    Garbers S, Jessop DJ, Foti H, Uribelarrea M, Chiasson MA. Barriers to breast cancer screening for low-income Mexican and Dominican women in New York City. J Urban Health. 2003; 80: 81-91.
  • 36
    Hyndman JC, Holman CD, Dawes VP. Effect of distance and social disadvantage on the response to invitations to attend mammography screening. J Med Screen. 2000; 7: 141-145.
  • 37
    van Ryn M, Burke J. The effect of patient race and socio-economic status on physicians' perceptions of patients. Soc Sci Med. 2000; 50: 813-828.
  • 38
    Zapka JG, Puleo E, Taplin SH, et al. Processes of care in cervical and breast cancer screening and follow-up—the importance of communication. Prev Med. 2004; 39: 81-90.
  • 39
    Cardenosa G, Eklund GW. Rate of compliance with recommendations for additional mammographic views and biopsies. Radiology. 1991; 181: 359-361.
  • 40
    Mandelblatt J, Traxler M, Lakin P, et al. Breast and cervical cancer screening of poor, elderly, black women: clinical results and implications. Harlem Study Team. Am J Prev Med. 1993; 9: 133-138.
  • 41
    O'Malley AS, Sheppard VB, Schwartz M, Mandelblatt J. The role of trust in use of preventive services among low-income African-American women. Prev Med. 2004; 38: 777-785.
  • 42
    Jones BA, Dailey A, Calvocoressi L, et al. Inadequate follow-up of abnormal screening mammograms: findings from the race differences in screening mammography process study (United States). Cancer Causes Control. 2005; 16: 809-821.
  • 43
    Schneider AE, Davis RB, Phillips RS. Discussion of hormone replacement therapy between physicians and their patients. Am J Med Qual. 2000; 15: 143-147.
  • 44
    Yabroff KR, Breen N, Vernon SW, Meissner HI, Freedman AN, Ballard-Barbash R. What factors are associated with diagnostic follow-up after abnormal mammograms? Findings from a US national survey. Cancer Epidemiol Biomarkers Prev. 2004; 13: 723-732.
  • 45
    Caplan LS, May DS, Richardson LC. Time to diagnosis and treatment of breast cancer: results from the National Breast and Cervical Cancer Early Detection Program, 1991-1995. Am J Public Health. 2000; 90: 130-134.
  • 46
    Gotay CC, Wilson ME. Social support and cancer screening in African American, Hispanic, and Native American women. Cancer Pract. 1998; 6: 31-37.
  • 47
    Katz SJ, Hofer TP. Socioeconomic disparities in preventive care persist despite universal coverage. Breast and cervical cancer screening in Ontario and the United States. JAMA. 1994; 272: 530-534.
  • 48
    Harris DM, Miller JE, Davis DM. Racial differences in breast cancer screening, knowledge and compliance. J Natl Med Assoc. 2003; 95: 693-701.
  • 49
    Howard DL, Penchansky R, Brown MB. Disaggregating the effects of race on breast cancer survival. Fam Med. 1998; 30: 228-235.
  • 50
    Reisch LM, Barton MB, Fletcher SW, Kreuter W, Elmore JG. Breast cancer screening use by African Americans and whites in an HMO. J Gen Intern Med. 2000; 15: 229-234.
  • 51
    Zackrisson S, Andersson I, Manjer J, Janzon L. Non-attendance in breast cancer screening is associated with unfavourable socio-economic circumstances and advanced carcinoma. Int J Cancer. 2004; 108: 754-760.
  • 52
    Richards MA, Westcombe AM, Love SB, Littlejohns P, Ramirez AJ. Influence of delay on survival in patients with breast cancer: a systematic review. Lancet. 1999; 353: 1119-1126.
  • 53
    Smith ER, Adams SA, Prabhu-Das I, Bottai M, Fulton J, Hebert JR. Breast cancer survival among economically disadvantaged women: the influences of delayed diagnosis and treatment on mortality. Cancer Epidemiol Biomarkers Prevent. 2008; 17: 2882-2890.